Determine That an Abbreviated New Drug Application (ANDA) Oxycodone Hydrochloride Extended-Release Capsules may be Submitted and be Considered Bioequivalent to the Reference Listed Drug (RLD) Oxycontin® (Oxycodone Hydrochloride Controlled-Release) Tablets | Federal Regulations · Congress.wiki